References
- Abbott J, Hawe J, Hunter D, Garry R. 2003. A double-blind randomized trial comparing the Cavaterm™ and the NovaSure™ endometrial ablation systems for the treatment of dysfunctional uterine bleeding. Fertility and Sterility 80:203–208.
- Adkins RT, Bressman PL, Bressman PB, Lucas TL. 2013. Radiofrequency endometrial ablation in patients with a history of low transverse cesarean delivery. Journal of Minimally Invasive Gynecology 20:848–852.
- Asgari Z, Moini A, Samiee H, Tehranian A, Mozafar-Jalali S, Sabet S. 2011. Endometrial ablation with the NovaSure system in Iran. International Journal of Gynecology & Obstetrics 114:73–75.
- Bansi-Matharu L, Gurol-Urganci I, Mahmood TA, Templeton A, Van der Meulen JH, Cromwell DA. 2013. Rates of subsequent surgery following endometrial ablation among English women with menorrhagia: population-based cohort study. BJOG: An International Journal of Obstetrics & Gynaecology 120:1500–1507.
- Baskett TF, Clough H, Scott TA. 2005. NovaSure Bipolar Radiofrequency endometrial ablation: report of 200 cases. Journal D'obstetrique et Gynecologie du Canada [Journal of Obstetrics and Gynaecology Canada] 27:473–476.
- Bhattacharya S, Middleton LJ, Tsourapas A, Lee AJ, Champaneria R, Daniels JP, et al. 2011. Hysterectomy, endometrial ablation and mirena® for heavy menstrual bleeding: a systematic review of clinical effectiveness and cost-effectiveness analysis. Health Technology Assessment 15:1–252.
- Bongers MY, Bourdrez P, Mol BWJ, Heintz APM, Brölmann HAM. 2004. Randomised controlled trial of bipolar radio-frequency endometrial ablation and balloon endometrial ablation. BJOG: An International Journal of Obstetrics and Gynaecology 111:1095–1102.
- Busund B, Erno L, Grønmark A, Istre O. 2003. Endometrial ablation with NovaSure™ GEA, a pilot study. Acta Obstetricia et Gynecologica Scandinavica 82:65–68.
- Cooper J, Gimpelson R, Laberge P, Galen D, Garza-Leal JG, Scott J, et al. 2002. A randomized, multicenter trial of safety and efficacy of the novasure system in the treatment of menorrhagia. The Journal of the American Association of Gynecologic Laparoscopists 9:418–428.
- Cooper K, Lee AJ, Chien P, Raja EA, Timmaraju V, Bhattacharya S. 2011. Outcomes following hysterectomy or endometrial ablation for heavy menstrual bleeding: retrospective analysis of hospital episode statistics in Scotland. BJOG: An International Journal of Obstetrics & Gynaecology 118:1171–1179.
- Cooper NA, Clark TJ. 2013. Ambulatory hysteroscopy. The Obstetrician & Gynaecologist 15:159–166.
- Davies A, Hart R, Magos A, Hadad E, Morris R. 2002. Hysterectomy: Surgical route and complications. European Journal of Obstetrics, Gynecology, and Reproductive Biology 104:148–151.
- Fergusson RJ, Rodriguez MB, Lethaby A, Farquhar C. 2019. Endometrial resection and ablation versus hysterectomy for heavy menstrual bleeding. Cochrane Database of Systematic Reviews. Available from: https://doi.org/10.1002/14651858.CD000329.pub3.
- Fulop T, Rakoczi I, Barna I. 2001. NovaSure impedance controlled endometrial ablation system: Long-term follow-up results. Proceedings of the Second World Congress on Controversies in Obstetrics, Gynecology and Infertility, 2: 149–155.
- Gallinat A. 2004. NovaSure impedance controlled system for endometrial ablation: Three-year follow-up on 107 patients. American Journal of Obstetrics and Gynecology 191:1585–1589.
- Gallinat A. 2007. An impedance-controlled system for endometrial ablation: five-year follow-up of 107 patients. The Journal of Reproductive Medicine 52:467–472.
- Getting It Right First Time (GIRFT) Academy. 2020. National day surgery delivery pack [Online] [cited 2021 Feb 22]. Available from: https://www.gettingitrightfirsttime.co.uk/wp-content/uploads/2020/10/National-Day-Surgery-Delivery-Pack_Sept2020_final.pdf.
- Gimpelson RJ. 2014. Ten-year literature review of global endometrial ablation with the NovaSure® device. International Journal of Women's Health 6:269–280.
- Hologic Gyn Surgical Solutions. 2020. NovaSure®Instructions for use and controller: operator’s manual [Online] [cited 2020]. Available from: https://www.hologic.com/sites/default/files/2019-07/AW-09898-000_012_02%20%281%29_RFC10%20controller%20IFU_Rev%2012.pdf.
- Kalkat RK, Cartmill RSV. 2011. NovaSure endometrial ablation under local anaesthesia in an outpatient setting: An observational study. Journal of Obstetrics and Gynaecology 31:152–155.
- Khan Z, El-Nashar SA, Hopkins MR, Famuyide AO. 2011. Efficacy and safety of global endometrial ablation after cesarean delivery: a cohort study. American Journal of Obstetrics and Gynecology 205:450.e1–450.e4.
- Kleijn JH, Engels R, Bourdrez P, Mol BW, Bongers MY. 2008. Five-year follow up of a randomised controlled trial comparing NovaSure and ThermaChoice endometrial ablation. BJOG : An International Journal of Obstetrics and Gynaecology 115:193–198.
- Lethaby A, Hickey M, Garry R, Penninx J. 2009. Endometrial resection/ablation techniques for heavy menstrual bleeding. Cochrane Database Syst Rev CD001501. Available from: https://doi.org/10.1002/14651858.CD001501.pub3.
- Lockhat FB, Emembolu JO, Konje JC. 2005. The efficacy, side-effects and continuation rates in women with symptomatic endometriosis undergoing treatment with an intra-uterine administered progestogen (levonorgestrel): a 3 year follow-up. Human Reproduction 20:789–793.
- Longinotti MK, Jacobson GF, Hung Y-Y, Learman LA. 2008. Probability of hysterectomy after endometrial ablation. Obstetrics & Gynecology 112:1214–1220.
- Marsh F, Kremer C, Duffy S. 2004. Delivering an effective outpatient service in gynaecology. A randomised controlled trial analysing the cost of outpatient versus daycase hysteroscopy. BJOG: An International Journal of Obstetrics and Gynaecology 111:243–248.
- Medicines and Healthcare Products Regulatory Agency (MHRA). 2010. Devices used for endometrial ablation – clinicians should confirm patients have no evidence of uterine perforation or false passage [Online] [cited 2021 Feb 22]. Available from: https://www.gov.uk/drug-device-alerts/medical-device-alert-devices-used-for-endometrial-ablation-clinicians-should-confirm-patients-have-no-evidence-of-uterine-perforation-or-false-passage.
- NHS Digital. 2020. Provisional monthly hospital episode statistics for admitted patient care and outpatient data April 2020 – July 2020 [Online] [cited February 22,]. Available from: https://digital.nhs.uk/data-and-information/publications/statistical/hospital-episode-statistics-for-admitted-patient-care-outpatient-and-accident-and-emergency-data/april-2020–-july-2020.
- NHS Health Research Authority (HRA). 2020. Governance Arrangements for Research Ethics Committees (GAfREC) [Online] [cited 2021 Feb 22]. Available from: http://www.hra.nhs.uk.
- R Core Team. 2020. R: a language and environment for statistical computing. Version 3.0.1 ed. Vienna, Austria: R Foundation for Statistical Computing.
- Reid PC. 2007. Endometrial ablation in England-coming of age? An examination of hospital episode statistics 1989/1990 to 2004/2005. European Journal of Obstetrics & Gynecology and Reproductive Biology 135:191–194.
- University College of London (UCL) Research Ethics Committee. 2018. Exemptions [Online] [cited , 2021 Feb 22]. Available: https://ethics.grad.ucl.ac.uk/exemptions.php.
- Wortman M. 2010. Instituting an office-based surgery program in the gynecologist's office. Journal of Minimally Invasive Gynecology 17:673–683.
- Wortman M. 2018. Endometrial ablation: past, present, and future part II. Surgical Technology International 33:161–177.
- Wortman M, Daggett A, Ball C. 2013. Operative hysteroscopy in an office-based surgical setting: review of patient safety and satisfaction in 414 cases. Journal of Minimally Invasive Gynecology 20:56–63.